Evidence map›Paper›PMID 36694918›Full record

ArticleTranslational behavioral medicine2023

Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancer.

Sara Gómez-Trillos, Kristi D Graves, Katie Fiallos, Marc D Schwartz, Beth N Peshkin, Heidi Hamilton, Vanessa B Sheppard, Susan T Vadaparampil, Claudia Campos, Ana Paula Cupertino and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Translational behavioral medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Sara Gómez-TrillosDepartment of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington DC, USA.ORCID 0000-0002-4145-7360
Kristi D GravesDepartment of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington DC, USA.ORCID 0000-0001-8808-1631
Katie FiallosKimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Marc D SchwartzDepartment of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington DC, USA.ORCID 0000-0002-2735-5413
Beth N PeshkinDepartment of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington DC, USA.
Heidi HamiltonDepartment of Linguistics, Georgetown University, Washington, DC, USA.
Vanessa B SheppardDepartment of Health Behavior and Policy, Virginia Commonwealth University, VA, USA.
Susan T VadaparampilDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.ORCID 0000-0002-1052-6917
Claudia CamposNueva Vida, Inc., Alexandria, VA, USA.
Ana Paula CupertinoSchool of Medicine and Dentistry, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
Maria C AlzamoraDepartment of Obstetrics and Gynecology, MedStar Washington Hospital Center/Georgetown University Hospital, Washington, DC, USA.
Filipa LynceDana-Farber Cancer Institute, Boston, MA, USA.
Alejandra Hurtado-de-MendozaDepartment of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington DC, USA.ORCID 0000-0003-1086-8869
Georgetown Lombardi Comprehensive Cancer CenterDana-Farber Cancer Institute · USGeorgetown University · USJohns Hopkins University · USMedStar Washington Hospital Center · USMoffitt Cancer Center · USNueva Vida · USUniversity of Rochester Medical Center · USVirginia Commonwealth University · US

Funding

Institutional Career Development CoreKL2TR001432 · NCATS · GEORGETOWN UNIVERSITY · PI UMANS, JASON G · 2015 to 2024
$7.5M
NCATS NIH HHS KL2 TR001432
6 · The paper itself

Abstract

Telephone genetic counseling (TGC) is accepted as standard clinical care for people seeking hereditary cancer risk assessment. TGC has been shown to be non-inferior to in-person genetic counseling, but trials have been conducted with a predominantly highly educated, non-Hispanic White population. This article describes the process of culturally adapting a TGC protocol and visual aid booklet for Spanish-preferring Latina breast cancer survivors at risk for hereditary breast and ovarian cancers. The adaptation process included two phases. Phase 1 involved a review of the literature and recommendations from an expert team including community partners. Phase 2 included interviews and a pilot with the target population (n = 14) to collect feedback about the adapted protocol and booklet following steps from the Learner Verification and Revision Framework. We describe the adaptation process and report the main adaptations following the Framework for Reporting Adaptations and Modifications to Evidence-based Interventions (FRAME). Adaptations in Phase 1 were responsive to the target population needs and characteristics (e.g., delivered in Spanish at an appropriate health literacy level, addressing knowledge gaps, targeting cultural values). Phase 2 interviews were crucial to refine details (e.g., selecting words) and to add components to address GCT barriers (e.g., saliva sample video). Cultural adaptations to evidence-based TGC protocols can increase the fit and quality of care for historically underserved populations. As TGC visits become routine in clinical care, it is crucial to consider the needs of diverse communities to adequately promote equity and justice in cancer care.

Indexed as

Breast NeoplasmsCancer SurvivorsOvarian NeoplasmsFemaleGenetic CounselingHispanic or LatinoHumansPamphletsReview Literature as TopicTelephoneCultural adaptationsEquityGenetic counselingHereditary breast and ovarian cancersTelehealth

Identifiers

PMID36694918
PMCPMC10182423
OpenAlexW4317910429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.